Close
Back to CTIC Stock Lookup
Pages: 1 2 3 4 5 »» Last Page

CTI BioPharma (CTIC) – Press Releases

Jun 26, 2023 09:45 AM Sobi completes acquisition of CTI BioPharma Corp.
Jun 24, 2023 06:49 AM Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp.
May 30, 2023 04:35 PM CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders
May 10, 2023 01:06 AM Sobi to Acquire CTI BioPharma
May 4, 2023 07:55 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2023 04:35 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 1, 2023 04:46 PM CTI BioPharma To Report First Quarter 2023 Financial Results and Provide Corporate Update on Thursday, May 11, 2023
May 1, 2023 07:03 AM CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 12, 2023 04:30 PM CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023
Apr 10, 2023 07:04 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 20, 2023 08:33 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 6, 2023 04:35 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 6, 2023 06:25 AM CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 1, 2023 04:20 PM CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference
Feb 23, 2023 07:03 AM CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023
Feb 7, 2023 08:28 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 2, 2023 07:00 AM CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023
Jan 24, 2023 07:18 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 5, 2023 07:00 AM CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
Dec 20, 2022 06:35 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 11, 2022 06:30 PM CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
Nov 30, 2022 07:00 AM CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit
Nov 8, 2022 04:05 PM CTI BioPharma to Present at Upcoming November Conferences
Nov 7, 2022 04:05 PM CTI BioPharma Reports Third Quarter 2022 Financial Results
Nov 3, 2022 09:00 AM CTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition
Oct 27, 2022 04:05 PM CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022
Oct 17, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 21, 2022 09:09 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 21, 2022 06:00 PM CTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting
Aug 22, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 8, 2022 04:05 PM CTI BioPharma Reports Second Quarter 2022 Financial Results
Aug 1, 2022 08:37 AM CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022
Jun 14, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 10, 2022 07:00 AM CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress
Jun 3, 2022 08:00 AM Celularity Appoints Industry Leader Diane Parks to its Board of Directors
Jun 2, 2022 04:05 PM CTI BioPharma to Present at Upcoming June Conferences
May 27, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2022 05:00 PM CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting
May 12, 2022 04:05 PM CTI BioPharma Reports First Quarter 2022 Financial Results
May 10, 2022 07:00 AM CTI BioPharma Announces Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
May 5, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 28, 2022 04:05 PM CTI BioPharma to Report First Quarter 2022 Financial Results on May 12, 2022
Apr 14, 2022 07:00 AM NCCN Guidelines® Recommend VONJO™ (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Apr 6, 2022 04:05 PM CTI BioPharma to Present at the 21st Annual Needham Virtual Healthcare Conference
Mar 31, 2022 04:01 PM CTI BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results
Mar 2, 2022 04:05 PM CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference
Feb 28, 2022 07:18 PM CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia
Feb 18, 2022 04:05 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 6, 2022 04:30 PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 13, 2021 09:00 AM CTI BioPharma Presents Data from Pacritinib Program at the 63rd American Society of Hematology Meeting
Pages: 1 2 3 4 5 »» Last Page

Back to CTIC Stock Lookup